• This topic is empty.
Viewing 0 reply threads
  • Author
    • #20679

      The study of temelimab has enrolled 42 people with relapsing MS whose disability progressed in the absence of relapses after treatment with rituximab. Click here to learn more.

      Are you following this study? What do you think of the findings so far?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2021 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account